The US Food and Drug Administration announced on Wednesday the approval of a treatment for pancreatic cancer, which could usher in a new era in the management of one of the deadliest forms of the disease. The drug, with the brand name Rasonque, is developed by the US startup Revolution Medicines. A clinical trial demonstrated […]
The post US regulator approves treatment for lethal pancreatic cancer appeared first on Insider Paper.
